221 related articles for article (PubMed ID: 26528288)
1. Predominant Role of Plasmacytoid Dendritic Cells in Stimulating Systemic Autoimmunity.
Huang X; Dorta-Estremera S; Yao Y; Shen N; Cao W
Front Immunol; 2015; 6():526. PubMed ID: 26528288
[TBL] [Abstract][Full Text] [Related]
2. A Plasmacytoid Dendritic Cells-Type I Interferon Axis Is Critically Implicated in the Pathogenesis of Systemic Lupus Erythematosus.
Kim JM; Park SH; Kim HY; Kwok SK
Int J Mol Sci; 2015 Jun; 16(6):14158-70. PubMed ID: 26110387
[TBL] [Abstract][Full Text] [Related]
3. Pivotal Functions of Plasmacytoid Dendritic Cells in Systemic Autoimmune Pathogenesis.
Cao W
J Clin Cell Immunol; 2014 Apr; 5(2):212. PubMed ID: 25077037
[TBL] [Abstract][Full Text] [Related]
4. Systematic identification of novel SLE related autoantibodies responsible for type I IFN production in human plasmacytoid dendritic cells.
Kassim SH; Jordan J; Schreiter J; Adhikarakunnathu S; Baribaud F; San Mateo L
Cell Immunol; 2013; 284(1-2):119-28. PubMed ID: 23973875
[TBL] [Abstract][Full Text] [Related]
5. New Treatments for Systemic Lupus Erythematosus on the Horizon: Targeting Plasmacytoid Dendritic Cells to Inhibit Cytokine Production.
Davison LM; Jorgensen TN
J Clin Cell Immunol; 2017; 8(6):. PubMed ID: 29430334
[TBL] [Abstract][Full Text] [Related]
6. Sialic acid-binding immunoglobulin-type lectin H-positive plasmacytoid dendritic cells drive spontaneous lupus-like disease development in B6.Nba2 mice.
Davison LM; Jørgensen TN
Arthritis Rheumatol; 2015 Apr; 67(4):1012-22. PubMed ID: 25504931
[TBL] [Abstract][Full Text] [Related]
7. A benzenediamine derivative fc-99 attenuates lupus-like syndrome in MRL/lpr mice related to suppression of pDC activation.
Ji J; Fan H; Li F; Li X; Dong G; Gong W; Song Y; Liu F; Hua C; Tan R; Dou H; Hou Y
Immunol Lett; 2015 Dec; 168(2):355-65. PubMed ID: 26545567
[TBL] [Abstract][Full Text] [Related]
8. Early, transient depletion of plasmacytoid dendritic cells ameliorates autoimmunity in a lupus model.
Rowland SL; Riggs JM; Gilfillan S; Bugatti M; Vermi W; Kolbeck R; Unanue ER; Sanjuan MA; Colonna M
J Exp Med; 2014 Sep; 211(10):1977-91. PubMed ID: 25180065
[TBL] [Abstract][Full Text] [Related]
9. Plasmacytoid dendritic cell distribution and maturation are altered in lupus prone mice prior to the onset of clinical disease.
Scott JL; Wirth JR; EuDaly JG; Gilkeson GS; Cunningham MA
Clin Immunol; 2017 Feb; 175():109-114. PubMed ID: 28041989
[TBL] [Abstract][Full Text] [Related]
10. B cell autophagy mediates TLR7-dependent autoimmunity and inflammation.
Weindel CG; Richey LJ; Bolland S; Mehta AJ; Kearney JF; Huber BT
Autophagy; 2015; 11(7):1010-24. PubMed ID: 26120731
[TBL] [Abstract][Full Text] [Related]
11. Neutrophils Regulate Humoral Autoimmunity by Restricting Interferon-γ Production via the Generation of Reactive Oxygen Species.
Huang X; Li J; Dorta-Estremera S; Di Domizio J; Anthony SM; Watowich SS; Popkin D; Liu Z; Brohawn P; Yao Y; Schluns KS; Lanier LL; Cao W
Cell Rep; 2015 Aug; 12(7):1120-32. PubMed ID: 26257170
[TBL] [Abstract][Full Text] [Related]
12. Systemic lupus erythematosus immune complexes increase the expression of SLAM family members CD319 (CRACC) and CD229 (LY-9) on plasmacytoid dendritic cells and CD319 on CD56(dim) NK cells.
Hagberg N; Theorell J; Schlums H; Eloranta ML; Bryceson YT; Rönnblom L
J Immunol; 2013 Sep; 191(6):2989-98. PubMed ID: 23956418
[TBL] [Abstract][Full Text] [Related]
13. Bcl-2 antagonists kill plasmacytoid dendritic cells from lupus-prone mice and dampen interferon-α production.
Zhan Y; Carrington EM; Ko HJ; Vikstrom IB; Oon S; Zhang JG; Vremec D; Brady JL; Bouillet P; Wu L; Huang DC; Wicks IP; Morand EF; Strasser A; Lew AM
Arthritis Rheumatol; 2015 Mar; 67(3):797-808. PubMed ID: 25418983
[TBL] [Abstract][Full Text] [Related]
14. Epicutaneous application of toll-like receptor 7 agonists leads to systemic autoimmunity in wild-type mice: a new model of systemic Lupus erythematosus.
Yokogawa M; Takaishi M; Nakajima K; Kamijima R; Fujimoto C; Kataoka S; Terada Y; Sano S
Arthritis Rheumatol; 2014 Mar; 66(3):694-706. PubMed ID: 24574230
[TBL] [Abstract][Full Text] [Related]
15. The development of litifilimab (BIIB 059) for cutaneous and systemic lupus erythematosus.
Cho YM; Furie R
Immunotherapy; 2024 Jan; 16(1):15-20. PubMed ID: 37877249
[TBL] [Abstract][Full Text] [Related]
16. Siglec-1-positive plasmacytoid dendritic cells (pDCs) in human peripheral blood: A semi-mature and myeloid-like subset imbalanced during protective and autoimmune responses.
Wilhelm TR; Taddeo A; Winter O; Schulz AR; Mälzer JN; Domingo C; Biesen R; Alexander T; Thiel A; Radbruch A; Hiepe F; Gerl V
Clin Immunol; 2016 Feb; 163():42-51. PubMed ID: 26674280
[TBL] [Abstract][Full Text] [Related]
17. TLR9/TLR7-triggered downregulation of BDCA2 expression on human plasmacytoid dendritic cells from healthy individuals and lupus patients.
Wu P; Wu J; Liu S; Han X; Lu J; Shi Y; Wang J; Lu L; Cao X
Clin Immunol; 2008 Oct; 129(1):40-8. PubMed ID: 18684674
[TBL] [Abstract][Full Text] [Related]
18. B lymphocytes enhance interferon-α production by plasmacytoid dendritic cells.
Berggren O; Hagberg N; Weber G; Alm GV; Rönnblom L; Eloranta ML
Arthritis Rheum; 2012 Oct; 64(10):3409-19. PubMed ID: 22736048
[TBL] [Abstract][Full Text] [Related]
19. Ablation of SigH+ pDCs in B6.Nba2 mice prevents lupus-like disease development only if started before disease is fully established.
Campbell NO; Davison LM; Banerjee S; Nguyen JK; Krafcik S; Silverman RH; Jorgensen TN
Lupus; 2022 Nov; 31(13):1619-1629. PubMed ID: 36134524
[TBL] [Abstract][Full Text] [Related]
20. Anti-interferon alpha treatment in SLE.
Kirou KA; Gkrouzman E
Clin Immunol; 2013 Sep; 148(3):303-12. PubMed ID: 23566912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
